MYLA software. Used to manage microbiology test workflow from the reception of requests to the t...

FDA Device Recall #Z-2225-2021 — Class II — June 22, 2021

Recall Summary

Recall Number Z-2225-2021
Classification Class II — Moderate risk
Date Initiated June 22, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm BioMerieux SA
Location Marcy L'Etoile, N/A
Product Type Devices
Quantity 248 systems

Product Description

MYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission of results by transferring, storing, and displaying medical device data.

Reason for Recall

Software anomaly - Under certain conditions, unwanted alterations to results could be applied when using the BCI Connect scripting feature.

Distribution Pattern

Distribution in the U.S. was nationwide. There was also military and government distribution.

Lot / Code Information

MYLA V4.8.0/4.8.1 and MYLA V4.7.0/V4.7.1 in conjunction with BCI CONNECT, UDI 03573026619244 and 03573026610975.

Other Recalls from BioMerieux SA

Recall # Classification Product Date
Z-0084-2022 Class II MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2... Sep 2, 2021
Z-0218-2019 Class II NucliSENS¿ Magnetic Extraction Reagents Sep 17, 2018
Z-2331-2018 Class II VIDAS FSH, Ref 30407-01, IVD, Rx. The firm nam... Apr 9, 2018
Z-2169-2018 Class II VIDAS TOXO IgG Avidity is an automated qualitat... Mar 23, 2018
Z-2171-2018 Class II Color Gram 2 (COLOR GRAM 2 - F), these stains a... Mar 23, 2018

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.